table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global RNA Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global RNA Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global RNA Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global RNA Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: RNA Drugs Industry Impact
Chapter 2 Global RNA Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global RNA Drugs (Volume and Value) by Type
2.1.1 Global RNA Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global RNA Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global RNA Drugs (Volume and Value) by Application
2.2.1 Global RNA Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global RNA Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global RNA Drugs (Volume and Value) by Regions
2.3.1 Global RNA Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global RNA Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global RNA Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global RNA Drugs Consumption by Regions (2016-2021)
4.2 North America RNA Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia RNA Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe RNA Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia RNA Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia RNA Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East RNA Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa RNA Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania RNA Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America RNA Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America RNA Drugs Market Analysis
5.1 North America RNA Drugs Consumption and Value Analysis
5.1.1 North America RNA Drugs Market Under COVID-19
5.2 North America RNA Drugs Consumption Volume by Types
5.3 North America RNA Drugs Consumption Structure by Application
5.4 North America RNA Drugs Consumption by Top Countries
5.4.1 United States RNA Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada RNA Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico RNA Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia RNA Drugs Market Analysis
6.1 East Asia RNA Drugs Consumption and Value Analysis
6.1.1 East Asia RNA Drugs Market Under COVID-19
6.2 East Asia RNA Drugs Consumption Volume by Types
6.3 East Asia RNA Drugs Consumption Structure by Application
6.4 East Asia RNA Drugs Consumption by Top Countries
6.4.1 China RNA Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan RNA Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea RNA Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe RNA Drugs Market Analysis
7.1 Europe RNA Drugs Consumption and Value Analysis
7.1.1 Europe RNA Drugs Market Under COVID-19
7.2 Europe RNA Drugs Consumption Volume by Types
7.3 Europe RNA Drugs Consumption Structure by Application
7.4 Europe RNA Drugs Consumption by Top Countries
7.4.1 Germany RNA Drugs Consumption Volume from 2016 to 2021
7.4.2 UK RNA Drugs Consumption Volume from 2016 to 2021
7.4.3 France RNA Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy RNA Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia RNA Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain RNA Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands RNA Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland RNA Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland RNA Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia RNA Drugs Market Analysis
8.1 South Asia RNA Drugs Consumption and Value Analysis
8.1.1 South Asia RNA Drugs Market Under COVID-19
8.2 South Asia RNA Drugs Consumption Volume by Types
8.3 South Asia RNA Drugs Consumption Structure by Application
8.4 South Asia RNA Drugs Consumption by Top Countries
8.4.1 India RNA Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan RNA Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh RNA Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia RNA Drugs Market Analysis
9.1 Southeast Asia RNA Drugs Consumption and Value Analysis
9.1.1 Southeast Asia RNA Drugs Market Under COVID-19
9.2 Southeast Asia RNA Drugs Consumption Volume by Types
9.3 Southeast Asia RNA Drugs Consumption Structure by Application
9.4 Southeast Asia RNA Drugs Consumption by Top Countries
9.4.1 Indonesia RNA Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand RNA Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore RNA Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia RNA Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines RNA Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam RNA Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar RNA Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East RNA Drugs Market Analysis
10.1 Middle East RNA Drugs Consumption and Value Analysis
10.1.1 Middle East RNA Drugs Market Under COVID-19
10.2 Middle East RNA Drugs Consumption Volume by Types
10.3 Middle East RNA Drugs Consumption Structure by Application
10.4 Middle East RNA Drugs Consumption by Top Countries
10.4.1 Turkey RNA Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia RNA Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran RNA Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates RNA Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel RNA Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq RNA Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar RNA Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait RNA Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman RNA Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa RNA Drugs Market Analysis
11.1 Africa RNA Drugs Consumption and Value Analysis
11.1.1 Africa RNA Drugs Market Under COVID-19
11.2 Africa RNA Drugs Consumption Volume by Types
11.3 Africa RNA Drugs Consumption Structure by Application
11.4 Africa RNA Drugs Consumption by Top Countries
11.4.1 Nigeria RNA Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa RNA Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt RNA Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria RNA Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco RNA Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania RNA Drugs Market Analysis
12.1 Oceania RNA Drugs Consumption and Value Analysis
12.2 Oceania RNA Drugs Consumption Volume by Types
12.3 Oceania RNA Drugs Consumption Structure by Application
12.4 Oceania RNA Drugs Consumption by Top Countries
12.4.1 Australia RNA Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand RNA Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America RNA Drugs Market Analysis
13.1 South America RNA Drugs Consumption and Value Analysis
13.1.1 South America RNA Drugs Market Under COVID-19
13.2 South America RNA Drugs Consumption Volume by Types
13.3 South America RNA Drugs Consumption Structure by Application
13.4 South America RNA Drugs Consumption Volume by Major Countries
13.4.1 Brazil RNA Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina RNA Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia RNA Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile RNA Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela RNA Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru RNA Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico RNA Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador RNA Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in RNA Drugs Business
14.1 Pfizer
14.1.1 Pfizer Company Profile
14.1.2 Pfizer RNA Drugs Product Specification
14.1.3 Pfizer RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Roche
14.2.1 Roche Company Profile
14.2.2 Roche RNA Drugs Product Specification
14.2.3 Roche RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Sanofi-Aventis
14.3.1 Sanofi-Aventis Company Profile
14.3.2 Sanofi-Aventis RNA Drugs Product Specification
14.3.3 Sanofi-Aventis RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Abbott Laboratories
14.4.1 Abbott Laboratories Company Profile
14.4.2 Abbott Laboratories RNA Drugs Product Specification
14.4.3 Abbott Laboratories RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Arrowhead Pharmaceuticals
14.5.1 Arrowhead Pharmaceuticals Company Profile
14.5.2 Arrowhead Pharmaceuticals RNA Drugs Product Specification
14.5.3 Arrowhead Pharmaceuticals RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Benitec Biopharma
14.6.1 Benitec Biopharma Company Profile
14.6.2 Benitec Biopharma RNA Drugs Product Specification
14.6.3 Benitec Biopharma RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Calimmune Inc
14.7.1 Calimmune Inc Company Profile
14.7.2 Calimmune Inc RNA Drugs Product Specification
14.7.3 Calimmune Inc RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Dicerna
14.8.1 Dicerna Company Profile
14.8.2 Dicerna RNA Drugs Product Specification
14.8.3 Dicerna RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Gradalis
14.9.1 Gradalis Company Profile
14.9.2 Gradalis RNA Drugs Product Specification
14.9.3 Gradalis RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Quark
14.10.1 Quark Company Profile
14.10.2 Quark RNA Drugs Product Specification
14.10.3 Quark RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 RXi
14.11.1 RXi Company Profile
14.11.2 RXi RNA Drugs Product Specification
14.11.3 RXi RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Senesco
14.12.1 Senesco Company Profile
14.12.2 Senesco RNA Drugs Product Specification
14.12.3 Senesco RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Silence Therapeutics
14.13.1 Silence Therapeutics Company Profile
14.13.2 Silence Therapeutics RNA Drugs Product Specification
14.13.3 Silence Therapeutics RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Silenseed
14.14.1 Silenseed Company Profile
14.14.2 Silenseed RNA Drugs Product Specification
14.14.3 Silenseed RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Tekmira
14.15.1 Tekmira Company Profile
14.15.2 Tekmira RNA Drugs Product Specification
14.15.3 Tekmira RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Alnylam Pharmaceuticals
14.16.1 Alnylam Pharmaceuticals Company Profile
14.16.2 Alnylam Pharmaceuticals RNA Drugs Product Specification
14.16.3 Alnylam Pharmaceuticals RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global RNA Drugs Market Forecast (2022-2027)
15.1 Global RNA Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global RNA Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global RNA Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global RNA Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global RNA Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global RNA Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America RNA Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global RNA Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global RNA Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global RNA Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global RNA Drugs Price Forecast by Type (2022-2027)
15.4 Global RNA Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 RNA Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
